Injective (INJ) is currently trading at $2.91, reflecting a minor decline of 0.35% over the past 24 hours. The price has oscillated between a high of $2.94 and a low of $2.89 during the same period, indicating a tight daily range of just 0.05%.

The trading volume stands at approximately $32.5 million, representing 11.19% of the market cap, which suggests a moderate level of market activity. Moving averages reveal mixed signals: the 8 SMA shows a slight upward trend at $2.90, while the 55 and 144 SMAs indicate a bearish trend, both at $2.96 with declines of 1.64% and 1.67%, respectively.

On the momentum indicators, the 1-hour RSI is at 54, while the 7-day RSI is slightly lower at 53, suggesting that momentum is relatively neutral and neither overbought nor oversold. The price changes indicate a short-term increase of nearly 0.95% over the last week, although the 14-day and 30-day changes reveal losses of approximately 0.94% and 4.40%, respectively.

Injective's all-time high of $52.62, reached in March 2024, demonstrates significant long-term potential, but the current price reflects a substantial retracement. This prolonged downtrend, alongside mixed technical indicators, highlights a period of consolidation and potential resistance around the $3 mark.

Given the current price action, volume metrics, and mixed moving average signals, the recommendation is to Hold Injective (INJ) at this time. This decision is based on the stabilization seen in the short term, while awaiting further confirmation of upward momentum before considering a Buy.